Corbus Pharmaceuticals
NASDAQ: CRBPNew York, US · Founded 2013 · 1 known investors
Corbus Pharmaceuticals develops targeted therapies for oncology and obesity, including CRB-913, an oral CB1 inverse agonist for weight loss. The company focuses on clinical-stage drug development to improve patient outcomes in cancer care and obesity treatment.
BiotechHealthtech
Founders & leadership
DH
David HochmanNamed on SEC filing
JB
John BrancaccioNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$6.4M disclosed across 3 rounds · 2013–2014
▶$6.3MraisedApr 2014 · 45 investors · InvestingRule 506(b)
▶$6.3MraisedApr 2014 · 45 investors · Investing
Rule 506(b)Officers, directors & promoters on the filing
- Robert ZurierExecutive Officer
- Yuval CohenExecutive Officer, Director
- Alan HolmerDirector
- Sean MoranExecutive Officer
- David HochmanDirector
- Mark TepperExecutive Officer
- Offering amount
- $13M
- Amount sold
- $6.3M
- Sales commissions
- $1.3M
- Placement agents
- Aegis Capital Corp.
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$19.8KraisedMar 2014 · 3 investors · InvestingRule 506(b)
▶$19.8KraisedMar 2014 · 3 investors · Investing
Rule 506(b)Officers, directors & promoters on the filing
- John BrancaccioExecutive Officer
- David HochmanExecutive Officer, Director
- Offering amount
- $30K
- Amount sold
- $19.8K
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$90KraisedJan 2014 · 19 investors · InvestingRule 506(b)
▶$90KraisedJan 2014 · 19 investors · Investing
Rule 506(b)Officers, directors & promoters on the filing
- David HochmanExecutive Officer, Director
- John BrancaccioExecutive Officer
- Offering amount
- $90K
- Amount sold
- $90K
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlapSeeking Alpha31 shared keywordsSeeking Alpha is a financial research platform that provides stock analysis, investment tools, and market coverage across asset classes to investors. The platform aggregates research from thousands of analysts and investors, offering ratings, articles, and investment ideas.
Simply Wall St30 shared keywordsSimply Wall St is a stock analysis platform that provides portfolio insights, stock discovery tools, and market alerts for individual investors. The service offers institutional-grade financial data visualization and analysis across 120,000 global stocks.
TipRanks29 shared keywordsFinancial analysis and stock research platform.
Public27 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
TradingView27 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Robinhood27 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies competing with Corbus Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Corbus Pharmaceuticals do?
- Corbus Pharmaceuticals develops targeted therapies for oncology and obesity, including CRB-913, an oral CB1 inverse agonist for weight loss. The company focuses on clinical-stage drug development to improve patient outcomes in cancer care and obesity treatment.
- Who are Corbus Pharmaceuticals's investors?
- Corbus Pharmaceuticals's investors include Boston Harbor Angels.
- How much funding has Corbus Pharmaceuticals raised?
- Corbus Pharmaceuticals has disclosed $6.4M raised across 3 rounds.
- Where is Corbus Pharmaceuticals headquartered?
- Corbus Pharmaceuticals is headquartered in New York, US.